Travere Therapeutics, Inc. Financial Ratios — TVTX Stock

Profitability (USD)

	2012 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	02/29/2012	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	-15.76	-19.88	-33.59	-54.29	-78.37	-70.17	-161.46	-91.44	-247.45	-29.38
Return on Assets (%)	-376.89	-2,533.75	-302.53	-142.26	36.2	-9.23	-11.42	-16.7	-22.29	-27.95	-26.02	-38.43	-15.24	-46.5	-4.26
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	97.98	97.81	96.59	97.67	96.63	97.01	96.91	97.1	95.96	92.12	96.68	97.89
EBITDA Margin (%)	- -	- -	- -	-263.83	-18.89	-17.07	-8.38	-30.46	-45.29	-25.61	-141.6	-273.25	-232.87	-119.15	-0.42
Operating Margin (%)	- -	- -	- -	-282.98	-32.29	-29.15	-19.88	-41.82	-56.92	-38.01	-151.27	-292.17	-259.4	-137.83	-12.8
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	-402.08	105.58	-43.1	-37.67	-62.02	-83.52	-95.19	-164.51	-302.54	-258.96	-137.45	-10.04
Profit Margin (%)	- -	- -	- -	-393.36	117.36	-35.86	-38.55	-62.51	-83.51	-85.43	-136.6	-254.41	-76.7	-137.9	-5.21
Net Income to Common Margin (%)	- -	- -	- -	-393.36	117.36	-35.86	-38.55	-62.51	-83.51	-85.43	-136.6	-254.41	-76.7	-137.9	-5.21
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	-15.76	-19.88	-33.59	-54.29	-78.37	-70.17	-161.46	-91.44	-247.45	-29.38

Credit (USD)

Credit Ratios API ChatGPT

	2012 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	02/29/2012	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	1	- -	84	44	44	45	218	205	244	262	407	405	402	329
ST Debt	- -	1	- -	40	- -	- -	- -	22	- -	- -	4	4	5	74	6
LT Debt	- -	- -	- -	43	44	44	45	195	205	244	258	403	400	328	323
Total Debt/EBITDA	-1.95	-0.03	- -	-1.13	-2.32	-1.95	-3.47	-4.35	-2.58	-4.8	-1.4	-1.36	-1.2	-1.45	-157.97
Net Debt/EBITDA	-1.64	-0.03	0.24	-0.88	-0.32	-0.15	4.18	-2.29	-1.79	-2.57	-0.33	-1.05	-0.94	-1.15	-105.09
Total Debt/EBIT	-1.95	-0.03	- -	-1.05	-1.36	-1.14	-1.46	-3.17	-2.05	-3.24	-1.31	-1.27	-1.07	-1.25	-5.23
Net Debt/EBIT	-1.64	-0.03	0.24	-0.82	-0.18	-0.09	1.76	-1.67	-1.43	-1.73	-0.31	-0.98	-0.85	-1	-3.48
EBITDA to Interest Expense	-6.41	-284.49	- -	- -	-2.44	-4.82	-2.94	-5.1	-4.22	-2.67	-9.48	-27.16	-29.84	-24.85	-0.19
EBITDA-CapEx/Interest Expense	-6.41	-295.75	- -	- -	-3.34	-7.34	-6.11	-7.11	-5.04	-8.96	-10.71	-29.75	-33.57	-33.9	-5.6
EBIT to Interest Expense	-6.41	-285.67	- -	- -	-4.16	-8.23	-6.96	-7	-5.3	-3.96	-10.13	-29.04	-33.24	-28.74	-5.85
Interest Expense	- -	- -	- -	- -	8	5	4	10	19	19	20	11	11	11	11
Common Equity/Total Assets	-1,613.74	-142.51	-95.94	-27.5	58.56	58.59	56.33	44.88	36.57	34.77	38.9	6.37	25.45	9.94	18.97
Long-Term Debt/Equity (%)	- -	- -	- -	- -	14.59	14.43	15.38	61.3	92.62	115.37	85.42	940.6	199.13	554.36	281.17
Long-Term Debt/Capital (%)	- -	- -	- -	93.05	12.73	12.61	13.33	36.41	48.08	53.53	45.75	89.5	66.03	71.09	72.79
Long-Term Debt/Total Assets (%)	- -	- -	- -	31.95	8.54	8.46	8.66	27.51	33.87	40.12	33.23	59.93	50.69	55.12	53.35
Total Debt/Equity (%)	-39.63	-25.96	- -	-224.89	14.59	14.43	15.38	68.36	92.62	115.54	86.72	950.94	201.58	679.76	286.28
Total Debt/Capital (%)	-65.65	-35.07	- -	180.07	12.73	12.61	13.33	40.6	48.08	53.6	46.44	90.48	66.84	87.18	74.11
Total Debt/Total Assets (%)	639.55	37	- -	61.84	8.54	8.46	8.66	30.68	33.87	40.17	33.73	60.59	51.31	67.59	54.32
Net Debt to Equity	-33.44	-25.63	30.49	-176.02	1.99	1.11	-18.53	36.03	64.39	61.82	20.13	732.44	158.9	542.43	190.45
Net Debt/Capital (%)	-50.23	-34.46	23.37	231.54	1.95	1.1	-22.74	26.49	39.17	35.24	15.27	80.76	58.29	79.69	62.39
EBITDA	- -	-30	-25	-74	-19	-23	-13	-50	-79	-51	-187	-299	-338	-278	-2
EBITDA-CapEx	- -	-31	-30	-78	-26	-35	-27	-70	-95	-171	-211	-328	-380	-379	-60
Operating Income (Loss)	- -	-30	-25	-80	-32	-39	-31	-69	-100	-75	-199	-320	-377	-321	-63

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2012 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	02/29/2012	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.06	- -	0.17	0.26	2.64	3.07	3.51	4.51	4.18	3.9	4.46	3.17	3.19	1.85	2.02
Current Ratio	0.06	0.01	0.21	0.35	3.47	3.99	3.8	4.74	4.5	4.43	4.7	3.42	3.47	2.08	2.74
Quick Ratio	0.06	- -	0.17	0.33	3.32	3.86	3.67	4.63	4.38	4.26	4.58	3.28	3.31	1.98	2.52
CFO/Avg Current Liab	- -	-0.93	-0.83	-0.64	-0.01	-0.04	0.09	-0.26	-0.58	-0.45	-0.14	-1.4	-1.75	-1.25	0.21
Common Equity/Total Assets	-1,613.74	-142.51	-95.94	-27.5	58.56	58.59	56.33	44.88	36.57	34.77	38.9	6.37	25.45	9.94	18.97
Long-Term Debt/Equity (%)	- -	- -	- -	- -	14.59	14.43	15.38	61.3	92.62	115.37	85.42	940.6	199.13	554.36	281.17
Long-Term Debt/Capital (%)	- -	- -	- -	93.05	12.73	12.61	13.33	36.41	48.08	53.53	45.75	89.5	66.03	71.09	72.79
Long-Term Debt/Total Assets (%)	- -	- -	- -	31.95	8.54	8.46	8.66	27.51	33.87	40.12	33.23	59.93	50.69	55.12	53.35
Total Debt/Equity (%)	-39.63	-25.96	- -	-224.89	14.59	14.43	15.38	68.36	92.62	115.54	86.72	950.94	201.58	679.76	286.28
Total Debt/Capital (%)	-65.65	-35.07	- -	180.07	12.73	12.61	13.33	40.6	48.08	53.6	46.44	90.48	66.84	87.18	74.11
Total Debt/Total Assets (%)	639.55	37	- -	61.84	8.54	8.46	8.66	30.68	33.87	40.17	33.73	60.59	51.31	67.59	54.32
CFO/Total Liabilities	-0.07	-47.19	-43.79	-26.55	-0.65	-1.58	3.26	-6.38	-15.18	-10.79	-3.12	-29.58	-47.61	-44.38	7.71
CFO/CapEx	- -	-2.29	-3.17	-11.57	-0.2	-0.29	0.53	-1.27	-3.74	-0.36	-0.61	-6.52	-6.63	-2.35	0.65
Altman's Z-Score	-78.93	-787.54	-24.89	-13.05	2.45	2.41	2.47	1.49	0.2	1.08	0.78	-2.11	-2.45	-3.58	1.31

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2012 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	02/29/2012	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	7.09	9.78	8.63	9.57	12.38	11.42	11.68	8.28	6.72	7.68	9.66	9.15
Days Sales Outstanding	- -	- -	- -	51.51	37.3	42.31	38.14	29.48	31.96	31.26	44.07	54.29	47.53	37.8	39.89
Inventory Turnover	- -	- -	- -	1.43	1.31	1.7	0.88	1.01	0.89	0.89	0.51	0.75	1.64	0.99	1.71
Days Inventory Outstanding	- -	- -	- -	256.01	278.72	214.88	413.95	362.23	407.99	407.84	713.22	488.7	222.08	367.88	213.14
Accounts Payable Turnover	- -	- -	- -	0.26	0.53	0.64	0.46	0.45	0.34	0.39	0.26	0.1	0.55	0.14	0.41
Accounts Payable Turnover Days	- -	- -	- -	1,420.3	687.31	571.2	787.76	815.41	1,075.33	924.11	1,413.02	3,631.41	658.7	2,624.76	880.86
Cash Conversion Cycle	- -	- -	- -	-1,112.78	-371.29	-314.01	-335.66	-423.7	-635.37	-485.01	-655.72	-3,088.42	-389.09	-2,219.08	-627.83
Inventory to Cash Days	- -	- -	- -	-204.5	-241.42	-172.57	-375.81	-332.74	-376.03	-376.58	-669.15	-434.42	-174.55	-330.08	-173.26
Inventories	- -	- -	- -	1	3	3	5	6	6	8	7	5	9	6	6
Raw Materials	- -	- -	- -	- -	- -	1	3	3	3	3	5	2	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	2	1	2	3	3	4	2	2	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	9	6	6

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2012 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	02/29/2012	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	30	129	319	703	718	830	937	612	1,424	1,940	1,352	678	1,523	3,474
- Cash & Cash Equivalents	- -	- -	6	18	38	41	99	103	62	85	166	62	58	59	93
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	1	- -	84	44	44	45	218	205	244	262	407	405	402	329
Enterprise Value	- -	31	123	375	518	506	574	683	418	1,306	1,649	1,309	515	1,554	3,480
Total Capital	- -	-3	-20	47	344	352	338	536	426	455	564	450	606	461	444
Total Debt/Capital (%)	-65.65	-35.07	- -	180.07	12.73	12.61	13.33	40.6	48.08	53.6	46.44	90.48	66.84	87.18	74.11
Total Debt / EV	1.19	0.03	- -	0.22	0.08	0.09	0.08	0.32	0.49	0.19	0.16	0.31	0.79	0.26	0.09
EV/Sales	- -	- -	- -	13.29	5.18	3.79	3.71	4.16	2.39	6.59	12.51	11.96	3.55	6.67	7.09
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	10.81	- -	- -	- -	71.65	1,017.83	48.12	- -	- -	- -	334.65	- -	- -	- -	71.39
EV/Free Cash Flow to Firm	10.81	- -	- -	- -	36.31	40.75	22.13	147.41	- -	13.87	56.7	- -	- -	- -	32.55
Diluted Market Cap	- -	12	99	307	725	725	817	915	601	1,296	1,857	1,341	668	1,374	3,409
Diluted Enterprise Value	- -	13	93	372	731	728	763	1,030	744	1,455	1,953	1,687	1,014	1,717	3,644
EV per Share	0.2	3.45	6.67	14.39	14.19	13.35	14.58	16.49	9.71	25.01	26.39	20.36	6.84	17.77	38.28
TTM Sales	- -	- -	- -	28	100	134	155	164	175	198	132	109	145	233	491
TTM EBITDA	- -	-30	-25	-74	-19	-23	-13	-50	-79	-51	-187	-299	-338	-278	-2
TTM Operating Income	- -	-30	-25	-80	-32	-39	-31	-69	-100	-75	-199	-320	-377	-321	-63
TTM Cash Flow to Firm	- -	-3	-18	-46	7	- -	12	-15	-39	-26	5	-175	-269	-226	49
TTM Free Cash Flow to Firm	- -	-1	-12	-42	14	12	26	5	-24	94	29	-147	-226	-125	107

Multiples (USD)

Valuation Multiples API ChatGPT

	2012 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	02/29/2012	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	-7.95	-8.26	-7.32	128.51	85.44	38.15	-174.05	-14.1	16.8	198.44	-8.5	-2.81	-10.09	35.53
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	31	123	375	518	506	574	683	418	1,306	1,649	1,309	515	1,554	3,480
Low Price	- -	1.5	3	7.19	11.87	11.6	15.55	20.09	10.87	8.98	12.75	17.97	5.25	5.12	12.91
EV/Sales	- -	- -	- -	13.29	5.18	3.79	3.71	4.16	2.39	6.59	12.51	11.96	3.55	6.67	7.09
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	5.52	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	-0.38	-2.45	-2.84	6.62	-13.69	-13.4	-10.24	-5.13	-5.18	-7.79	-5.65	-10.12	-2.67	-77.24
Price/Earnings High	- -	-0.93	-4.1	-5.48	10.6	-18.98	-17.16	-12.99	-7.14	-7.91	-10.99	-7.21	-15.45	-4.99	-147.13
Price/Earnings Low	- -	-0.18	-1.23	-1.62	3.4	-8.96	-10.09	-7.91	-3.14	-2.52	-4.24	-4.11	-3.5	-1.26	-45.08
Price/Book Value	- -	-8.8	-6.55	-8.56	2.34	2.33	2.83	2.94	2.77	6.74	6.42	31.55	3.37	25.79	30.26
Price/Book Value Average	- -	-8.34	-5.58	-8.78	2.81	2.18	2.77	3.38	3.45	4.57	4.85	37.02	5.69	16.08	17.51
Price/Book Value High	- -	-20.2	-9.35	-16.96	4.5	3.03	3.55	4.29	4.81	6.97	6.84	47.27	8.7	30.09	33.36
Price/Book Value Low	- -	-3.94	-2.81	-5.03	1.44	1.43	2.09	2.61	2.12	2.22	2.64	26.96	1.97	7.58	10.22
Price/Tangible Book Value	- -	-5.35	-4	-2.41	5.12	5.75	7.73	7.17	9.7	24.94	12.62	-24.91	7.03	-34.51	2,028.12
Price/Tangible Book Value Average	- -	-5.07	-3.4	-2.47	6.14	5.39	7.57	8.24	12.11	16.91	9.53	-29.23	11.87	-21.52	1,174.01
Price/Tangible Book Value High	- -	-12.28	-5.7	-4.77	9.82	7.46	9.69	10.46	16.87	25.8	13.45	-37.32	18.14	-40.28	2,236.18
Price/Tangible Book Value Low	- -	-2.4	-1.71	-1.41	3.15	3.52	5.7	6.37	7.43	8.22	5.18	-21.29	4.11	-10.14	685.24
Price/Sales	- -	- -	- -	10.87	6.48	5.24	5.27	5.57	3.43	6.53	14.09	12.25	4.6	5.89	6.95
Price/Sales Average	- -	- -	- -	11.15	7.77	4.91	5.17	6.4	4.28	4.43	10.64	14.37	7.76	3.68	4.02
Price/Sales High	- -	- -	- -	21.55	12.44	6.8	6.62	8.12	5.96	6.76	15.02	18.35	11.85	6.88	7.66
Price/Sales Low	- -	- -	- -	6.39	3.99	3.21	3.89	4.95	2.62	2.15	5.79	10.47	2.68	1.73	2.35
Price/Cash Flow	- -	-4.48	-5.65	-6.69	-466.07	-203.54	110.34	-36.66	-10.33	-30.31	-125.55	-7.2	-2.38	-5.79	90.22
Price/Cash Flow Average	- -	-4.25	-4.81	-6.86	-558.96	-190.64	108.13	-42.12	-12.89	-20.55	-94.81	-8.45	-4.02	-3.61	52.22
Price/Cash Flow High	- -	-10.29	-8.07	-13.25	-894.94	-264.18	138.47	-53.46	-17.96	-31.35	-133.85	-10.78	-6.15	-6.75	99.47
Price/Cash Flow Low	- -	-2.01	-2.42	-3.93	-286.8	-124.72	81.44	-32.55	-7.91	-9.99	-51.57	-6.15	-1.39	-1.7	30.48
Price/Free Cash Flow Average	- -	-7.53	-7.03	-7.51	154.13	80.03	37.39	-199.95	-17.6	11.39	149.84	-9.97	-4.74	-6.29	20.57
Price/Free Cash Flow High	- -	-18.24	-11.79	-14.51	246.77	110.9	47.87	-253.81	-24.51	17.38	211.54	-12.73	-7.24	-11.77	39.18
Price/Free Cash Flow Low	- -	-3.56	-3.54	-4.3	79.08	52.36	28.16	-154.52	-10.79	5.54	81.51	-7.26	-1.64	-2.96	12
EV/Sales Average	- -	- -	- -	13.92	8.5	5.06	4.9	7.25	5.17	5.67	11.84	17.65	10.26	5.55	4.58
EV/Sales High	- -	- -	- -	24.72	13.58	7	6.37	9.01	6.88	8.23	16.41	21.66	14.42	9.1	8.29
EV/Sales Low	- -	- -	- -	8.97	4.39	3.32	3.6	5.76	3.48	3.17	6.77	13.71	5.11	3.39	2.87
EV/EBITDA Average	-1.64	-0.97	-4.23	-5.28	-45.03	-29.62	-58.4	-23.8	-11.41	-22.14	-8.36	-6.46	-4.41	-4.65	-1,079.67
EV/EBITDA High	-1.64	-2.31	-7.25	-9.37	-71.9	-40.99	-75.96	-29.6	-15.19	-32.13	-11.59	-7.93	-6.19	-7.63	-1,954
EV/EBITDA Low	-1.64	-0.47	-2.01	-3.4	-23.26	-19.43	-42.95	-18.91	-7.69	-12.37	-4.78	-5.02	-2.19	-2.85	-677.32
EV/EBIT Average	-1.64	-0.97	-4.19	-4.92	-26.34	-17.35	-24.64	-17.33	-9.08	-14.92	-7.83	-6.04	-3.96	-4.02	-35.76
EV/EBIT High	-1.64	-2.3	-7.18	-8.74	-42.05	-24.01	-32.04	-21.55	-12.09	-21.65	-10.85	-7.41	-5.56	-6.6	-64.72
EV/EBIT Low	-1.64	-0.47	-1.99	-3.17	-13.6	-11.38	-18.12	-13.77	-6.12	-8.34	-4.48	-4.69	-1.97	-2.46	-22.44
Last Price	- -	3.35	7	12.24	19.29	18.93	21.07	22.63	14.2	27.26	31.04	21.03	8.99	17.42	38.21
High Price	- -	7.69	9.99	24.25	37.04	24.57	26.44	33	24.69	28.19	33.09	31.5	23.18	20.33	42.13
Enterprise Value Average	- -	29	104	393	850	676	759	1,191	906	1,125	1,561	1,932	1,490	1,293	2,247
Enterprise Value High	- -	70	178	697	1,357	935	987	1,481	1,206	1,632	2,164	2,371	2,094	2,121	4,066
Enterprise Value Low	- -	14	49	253	439	443	558	946	611	628	893	1,501	742	791	1,410

Shares Outstanding	- -	9	18	26	36	38	39	41	43	52	62	64	75	87	91
Diluted Weighted Avg Shares	- -	4	14	25	38	38	39	40	42	48	60	64	74	79	89
Basic Weighted Avg Shares	- -	4	14	25	34	37	39	40	42	48	60	64	74	79	89
Revenue per Share	- -	- -	- -	1.13	2.98	3.61	4	4.06	4.14	4.17	2.2	1.72	1.96	2.96	5.5
EBITDA per Share	-0.12	-8.23	-1.73	-2.97	-0.56	-0.62	-0.34	-1.24	-1.88	-1.07	-3.12	-4.69	-4.55	-3.52	-0.02
Operating Income per Share	-0.12	-8.26	-1.74	-3.18	-0.96	-1.05	-0.79	-1.7	-2.36	-1.59	-3.33	-5.02	-5.07	-4.07	-0.7
Basic EPS, GAAP	-0.14	-8.29	-2.44	-4.43	3.49	-1.29	-1.54	-2.54	-3.46	-3.56	-3.01	-4.37	-1.5	-4.08	-0.29
Basic EPS from Cont Ops	-0.14	-8.29	-2.44	-4.43	3.49	-1.29	-1.54	-2.54	-3.46	-3.56	-3.63	-5.2	-5.07	-4.06	-0.56
Diluted EPS, GAAP	-0.14	-8.29	-2.44	-4.43	3.12	-1.25	-1.54	-2.54	-3.46	-3.56	-3.01	-4.37	-1.5	-4.08	-0.29
Diluted EPS from Cont Ops	-0.14	-8.29	-2.44	-4.43	3.12	-1.25	-1.54	-2.54	-3.46	-3.56	-3.63	-5.2	-5.07	-4.06	-0.56
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	-0.75	-1.24	-1.83	-0.04	-0.09	0.19	-0.62	-1.37	-0.9	-0.25	-2.92	-3.77	-3.01	0.42
Free Cash Flow per Basic Share	- -	-1.07	-1.63	-1.99	-0.25	-0.42	-0.17	-1.1	-1.74	-3.42	-0.65	-3.37	-4.34	-4.29	-0.23
Cash & Equivalents per Share	0.04	- -	0.33	1.07	6.3	6.75	7.64	11.39	9.25	6.92	8.85	7	7.52	4.24	3.55
Book Value per Share	-0.59	-0.38	-1.07	-1.43	8.23	8.12	7.44	7.69	5.13	4.04	4.83	0.67	2.66	0.68	1.26
Tangible Book Value per Share	-0.59	-0.63	-1.75	-5.08	3.77	3.29	2.73	3.16	1.46	1.09	2.46	-0.84	1.28	-0.5	0.02

Travere Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)